IBDEI2TM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47353,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,47354,0)
 ;;=C82.40^^209^2346^189
 ;;^UTILITY(U,$J,358.3,47354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47354,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,47354,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,47354,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,47355,0)
 ;;=C82.41^^209^2346^182
 ;;^UTILITY(U,$J,358.3,47355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47355,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47355,1,4,0)
 ;;=4^C82.41
 ;;^UTILITY(U,$J,358.3,47355,2)
 ;;=^5001502
 ;;^UTILITY(U,$J,358.3,47356,0)
 ;;=C82.42^^209^2346^186
 ;;^UTILITY(U,$J,358.3,47356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47356,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47356,1,4,0)
 ;;=4^C82.42
 ;;^UTILITY(U,$J,358.3,47356,2)
 ;;=^5001503
 ;;^UTILITY(U,$J,358.3,47357,0)
 ;;=C82.43^^209^2346^184
 ;;^UTILITY(U,$J,358.3,47357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47357,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47357,1,4,0)
 ;;=4^C82.43
 ;;^UTILITY(U,$J,358.3,47357,2)
 ;;=^5001504
 ;;^UTILITY(U,$J,358.3,47358,0)
 ;;=C82.44^^209^2346^180
 ;;^UTILITY(U,$J,358.3,47358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47358,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47358,1,4,0)
 ;;=4^C82.44
 ;;^UTILITY(U,$J,358.3,47358,2)
 ;;=^5001505
 ;;^UTILITY(U,$J,358.3,47359,0)
 ;;=C82.45^^209^2346^183
 ;;^UTILITY(U,$J,358.3,47359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47359,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47359,1,4,0)
 ;;=4^C82.45
 ;;^UTILITY(U,$J,358.3,47359,2)
 ;;=^5001506
 ;;^UTILITY(U,$J,358.3,47360,0)
 ;;=C82.46^^209^2346^185
 ;;^UTILITY(U,$J,358.3,47360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47360,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47360,1,4,0)
 ;;=4^C82.46
 ;;^UTILITY(U,$J,358.3,47360,2)
 ;;=^5001507
 ;;^UTILITY(U,$J,358.3,47361,0)
 ;;=C82.47^^209^2346^188
 ;;^UTILITY(U,$J,358.3,47361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47361,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Spleen
 ;;^UTILITY(U,$J,358.3,47361,1,4,0)
 ;;=4^C82.47
 ;;^UTILITY(U,$J,358.3,47361,2)
 ;;=^5001508
 ;;^UTILITY(U,$J,358.3,47362,0)
 ;;=C82.48^^209^2346^187
 ;;^UTILITY(U,$J,358.3,47362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47362,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47362,1,4,0)
 ;;=4^C82.48
 ;;^UTILITY(U,$J,358.3,47362,2)
 ;;=^5001509
 ;;^UTILITY(U,$J,358.3,47363,0)
 ;;=C82.49^^209^2346^181
 ;;^UTILITY(U,$J,358.3,47363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47363,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47363,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,47363,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,47364,0)
 ;;=C82.50^^209^2346^123
 ;;^UTILITY(U,$J,358.3,47364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47364,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47364,1,4,0)
 ;;=4^C82.50
 ;;^UTILITY(U,$J,358.3,47364,2)
 ;;=^5001511
 ;;^UTILITY(U,$J,358.3,47365,0)
 ;;=C82.51^^209^2346^116
 ;;^UTILITY(U,$J,358.3,47365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47365,1,3,0)
 ;;=3^Diffuse Follicle Center Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47365,1,4,0)
 ;;=4^C82.51
 ;;^UTILITY(U,$J,358.3,47365,2)
 ;;=^5001512
